DrugPatentWatch Database Preview
Profile for Hong Kong Patent: 1054319
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Hong Kong Patent: 1054319
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | May 25, 2020 | Alkermes | VIVITROL | naltrexone |
Start Trial | May 25, 2020 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
Start Trial | May 25, 2020 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
Start Trial | May 25, 2020 | Alkermes | VIVITROL | naltrexone |
Start Trial | May 25, 2020 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
Start Trial | May 25, 2020 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |